UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

DNA polymerase ε and δ proofreading suppress discrete mutator and cancer phenotypes in mice

Proceedings of the National Academy of Sciences - PNAS, 2009-10, Vol.106 (40), p.17101-17104

2009

Volltextzugriff (PDF)

Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study

The Lancet (British edition), 2020-09, Vol.396 (10254), p.839-852

2020

Volltextzugriff (PDF)

DNA replication fidelity and cancer

Seminars in cancer biology, 2010-10, Vol.20 (5), p.281-293

2010

Volltextzugriff (PDF)

DNA Replication Fidelity: Proofreading in Trans

Current biology, 2006-03, Vol.16 (6), p.R209-R211

2006

Volltextzugriff (PDF)

A Bayesian adaptive phase 1 design to determine the optimal dose and schedule of an adoptive T-cell therapy in a mixed patient population

Contemporary clinical trials, 2016-05, Vol.48, p.153-165

2016

Volltextzugriff (PDF)

Updated safety and long term clinical outcomes in TRANSCEND NHL 001, pivotal trial of lisocabtagene maraleucel (JCAR017) in R/R aggressive NHL

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.7505-7505

2018

Volltextzugriff (PDF)

Case Series: Acute Tumor Lysis Syndrome in Mutator Mice with Disseminated Lymphoblastic Lymphoma

Toxicologic pathology, 2010-04, Vol.38 (3), p.476-485

2010

Volltextzugriff (PDF)

Divergent cellular phenotypes of human and mouse cells lacking the Werner syndrome RecQ helicase

DNA repair, 2010-01, Vol.9 (1), p.11-22

2010

Volltextzugriff (PDF)

Characterization of cytokine release syndrome (CRS) and neurological events (NEs) in the phase I TRANSCEND NHL 001 trial of lisocabtagene maraleucel (liso-cel) for patients (pts) with relapsed/refractory (R/R) large B-cell lymphoma (LBCL)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e20046-e20046

2020

Volltextzugriff (PDF)

EARLY FLOWERING3 Encodes a Novel Protein That Regulates Circadian Clock Function and Flowering in Arabidopsis

The Plant cell, 2001-06, Vol.13 (6), p.1281-1292

Hicks, K. A.

2001

Volltextzugriff (PDF)

Abstract 4642: Model-based alternative clinical trial designs and evaluations for SGN-CD19A, a novel antibody-drug conjugate

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.4642-4642

2014

Volltextzugriff (PDF)

Abstract DDT01-04: SGN-CD19A: A novel Anti-CD19 antibody drug conjugate

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.DDT01-04-DDT01-04

2014

Volltextzugriff (PDF)

CR rates in relapsed/refractory (R/R) aggressive B-NHL treated with the CD19-directed CAR T-cell product JCAR017 (TRANSCEND NHL 001)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.7513-7513

2017

Volltextzugriff (PDF)

Transcend NHL 001: Immunotherapy with the CD19-Directed CAR T-Cell Product JCAR017 Results in High Complete Response Rates in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Blood, 2016-12, Vol.128 (22), p.4192-4192

2016

Volltextzugriff (PDF)

Abstract 2412: Phase 1, open-label, dose-escalation studies of SGN-CD19A in patients with relapsed or refractory B-lineage acute leukemia and non-Hodgkin lymphoma

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.2412-2412

2013

Volltextzugriff (PDF)

Interim analysis of a phase 1, open-label, dose-escalation study of SGN-CD19A in patients with relapsed or refractory B-lineage non-Hodgkin lymphoma (NHL)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.8505-8505

2014

Volltextzugriff (PDF)

EARLY FLOWERING3 Encodes a Novel Protein That Regulates Circadian Clock Function and Flowering in Arabidopsis

The Plant cell, 2001-06, Vol.13 (6), p.1281-1292

2001

Volltextzugriff (PDF)

Interim Analysis of a Phase 1 Study of the Antibody-Drug Conjugate SGN-CD19A in Relapsed or Refractory B-Lineage Acute Leukemia and Highly Aggressive Lymphoma

Blood, 2014-12, Vol.124 (21), p.963-963

2014

Volltextzugriff (PDF)

A First-In-Human Phase 1 Study Of The Antibody-Drug Conjugate SGN-CD19A In Relapsed Or Refractory B-Lineage Acute Leukemia and Highly Aggressive Lymphoma

Blood, 2013-11, Vol.122 (21), p.1437-1437

2013

Volltextzugriff (PDF)

Polymerase delta and epsilon proofreading cooperate with MMR to suppress lethal mutations and cancer in mice

The FASEB journal, 2010-04, Vol.24 (S1), p.491.1-491.1

2010

Volltextzugriff (PDF)

DNA polymerase [epsilon] and [delta] proofreading suppress discrete mutator and cancer phenotypes in mice

Proceedings of the National Academy of Sciences - PNAS, 2009-10, Vol.106 (40), p.17101

2009

Volltextzugriff (PDF)

DNA polymerase I mu and delta proofreading suppress discrete mutator and cancer phenotypes in mice

Proceedings of the National Academy of Sciences - PNAS, 2009-01, Vol.106 (40), p.17101-17104

2009

Volltextzugriff (PDF)

DNA polymerase Îµ and Î´ proofreading suppress discrete mutator and cancer phenotypes in mice

Proceedings of the National Academy of Sciences - PNAS, 2009, Vol.106 (40), p.17101-17104

2009

Volltextzugriff (PDF)

EARLY FLOWERING3 Encodes a Novel Protein That Regulates Circadian Clock Function and Flowering in Arabidopsis

The Plant cell, 2001-06, Vol.13 (6), p.1281

2001

Volltextzugriff (PDF)

Multiplex polymerase chain reaction pathogen detection in patients with suspected septicemia after trauma, emergency, and burn surgery

Surgery, 2012-03, Vol.151 (3), p.456-463

2012

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(10)
Life Sciences & Biomedicine
(9)
Animals
(5)
Humans
(5)
Mice
(4)
Mutation
(4)
Biological And Medical Sciences
(3)
Cancer
(3)
Dna
(3)
Dna Polymerase
(3)
Dna Replication
(3)
Female
(3)
Hematology, Oncology And Palliative Medicine
(3)
Male
(3)
Mismatch Repair
(3)
Neoplasms - Genetics
(3)
Phenotype
(3)
Aged
(2)
Base Sequence
(2)
Biochemistry & Molecular Biology
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

DNA polymerase ε and δ proofreading suppress discrete mutator and cancer phenotypes in mice

Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study

DNA replication fidelity and cancer

DNA Replication Fidelity: Proofreading in Trans

A Bayesian adaptive phase 1 design to determine the optimal dose and schedule of an adoptive T-cell therapy in a mixed patient population

Updated safety and long term clinical outcomes in TRANSCEND NHL 001, pivotal trial of lisocabtagene maraleucel (JCAR017) in R/R aggressive NHL

Case Series: Acute Tumor Lysis Syndrome in Mutator Mice with Disseminated Lymphoblastic Lymphoma

Divergent cellular phenotypes of human and mouse cells lacking the Werner syndrome RecQ helicase

Characterization of cytokine release syndrome (CRS) and neurological events (NEs) in the phase I TRANSCEND NHL 001 trial of lisocabtagene maraleucel (liso-cel) for patients (pts) with relapsed/refractory (R/R) large B-cell lymphoma (LBCL)

EARLY FLOWERING3 Encodes a Novel Protein That Regulates Circadian Clock Function and Flowering in Arabidopsis

Abstract 4642: Model-based alternative clinical trial designs and evaluations for SGN-CD19A, a novel antibody-drug conjugate

Abstract DDT01-04: SGN-CD19A: A novel Anti-CD19 antibody drug conjugate

CR rates in relapsed/refractory (R/R) aggressive B-NHL treated with the CD19-directed CAR T-cell product JCAR017 (TRANSCEND NHL 001)

Transcend NHL 001: Immunotherapy with the CD19-Directed CAR T-Cell Product JCAR017 Results in High Complete Response Rates in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Abstract 2412: Phase 1, open-label, dose-escalation studies of SGN-CD19A in patients with relapsed or refractory B-lineage acute leukemia and non-Hodgkin lymphoma

Interim analysis of a phase 1, open-label, dose-escalation study of SGN-CD19A in patients with relapsed or refractory B-lineage non-Hodgkin lymphoma (NHL)

EARLY FLOWERING3 Encodes a Novel Protein That Regulates Circadian Clock Function and Flowering in Arabidopsis

Interim Analysis of a Phase 1 Study of the Antibody-Drug Conjugate SGN-CD19A in Relapsed or Refractory B-Lineage Acute Leukemia and Highly Aggressive Lymphoma

A First-In-Human Phase 1 Study Of The Antibody-Drug Conjugate SGN-CD19A In Relapsed Or Refractory B-Lineage Acute Leukemia and Highly Aggressive Lymphoma

Polymerase delta and epsilon proofreading cooperate with MMR to suppress lethal mutations and cancer in mice

DNA polymerase [epsilon] and [delta] proofreading suppress discrete mutator and cancer phenotypes in mice

DNA polymerase I mu and delta proofreading suppress discrete mutator and cancer phenotypes in mice

DNA polymerase Îµ and Î´ proofreading suppress discrete mutator and cancer phenotypes in mice

EARLY FLOWERING3 Encodes a Novel Protein That Regulates Circadian Clock Function and Flowering in Arabidopsis

Multiplex polymerase chain reaction pathogen detection in patients with suspected septicemia after trauma, emergency, and burn surgery

Suchergebnisse filtern